| Literature DB >> 22560213 |
Abstract
Fatty acids (FA) and FA-derived metabolites have long been implicated in the development of insulin resistance and type 2 diabetes. Surprisingly, application of metabolomics technologies has revealed that branched-chain amino acids (BCAA) and related metabolites are more strongly associated with insulin resistance than many common lipid species. Moreover, the BCAA-related signature is predictive of incident diabetes and intervention outcomes and uniquely responsive to therapeutic interventions. Nevertheless, in animal feeding studies, BCAA supplementation requires the background of a high-fat diet to promote insulin resistance. This Perspective develops a model to explain how lipids and BCAA may synergize to promote metabolic diseases.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22560213 PMCID: PMC3695706 DOI: 10.1016/j.cmet.2012.01.024
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287